Latest Commercial Scale Up News

AVA Risk Group has locked in a strategic investment of up to A$12.6 million from US-based Hale Capital, aiming to boost its footprint in the lucrative US critical infrastructure market. The deal includes convertible notes and warrants priced at an 81% premium, alongside a new board appointment.

Enlitic has locked in commitments for an A$8 million convertible note capital raise, with initial funds arriving immediately and the remainder pending shareholder approval. This funding aims to extend the company’s runway as it advances its AI-driven healthcare solutions.

Nanoveu Limited has announced the tape-out of its next-generation ECS-DoT 16nm integrated circuit, alongside key collaborations with Arrow Electronics and Semtech, signaling a strong push into the ultra-low-power Edge AI market.

First Graphene has successfully produced 600 tonnes of graphene enhanced cement, marking a key milestone in sustainable construction with significant CO2 reductions and multiple UK trial projects underway.

Talga Group launches a $5 million Share Purchase Plan at a discounted price of $0.41 per share, offering eligible shareholders free attaching options as it advances its battery anode production expansion.

Elevate Uranium has successfully assembled its U-pgrade™ Demonstration/Pilot Plant in Namibia, with steady state operations expected to start in January 2026. This milestone aims to validate a proprietary beneficiation process that could transform uranium processing economics.

Askari Metals advances its flagship Nejo Project in Ethiopia with strong government backing and a planned maiden drilling campaign targeting high-grade gold zones. The company is well funded and poised for a busy 2026 exploration season.

Prairie Lithium has locked in a decade-long agreement to supply lithium-bearing crystallite to Hydro Lithium’s South Korean refinery, marking a strategic step in its commercial-scale production and market entry.

Firebird Metals has achieved a significant technical milestone with its manganese iron phosphate precursor outperforming China industry benchmarks, setting the stage for commercial production at its Australian Demonstration Plant in 2026.

Pathkey.AI Ltd has announced a pro rata non-renounceable rights issue to raise approximately $920,517, alongside a $2.5 million placement, aiming to fund enhancements to its AI platform and strategic expansion.

Neurizon Therapeutics has completed manufacturing three GMP registration batches of its lead ALS drug candidate NUZ-001 ahead of schedule, paving the way for FDA submissions and clinical trial enrollment.

Talga Group has applied for a SEK 1.1 billion grant to fund a commercial-scale battery anode plant in Sweden, complementing existing EU funding and securing strong customer interest.